FDA Clears Abbott’s Genetic FISH Panel for Leukemia Patient Prognosis
22 August 2011 | By
Abbott has received 510k clearance from the FDA...
List view / Grid view
22 August 2011 | By
Abbott has received 510k clearance from the FDA...
22 August 2011 | By GlaxoSmithKline
GSK will receive a 25.4% minority equity stake, representing a £1,250,000 investment, in Autifony Therapeutics Limited...
19 August 2011 | By The Scott Partnership
FFF technology combined with MALS & QELS enables rapid measurements of particle size, size distribution, particle count, & structure...
18 August 2011 | By
Merck to pay ARIAD $25 million milestone payment for acceptance of filing...
17 August 2011 | By Pfizer
EMA accepted Pfizer’s regulatory submissions for review of two investigational compounds...
17 August 2011 | By Daiichi Sankyo
First-in-class treatment option soon available to treat deadly form of skin cancer...
17 August 2011 | By Roche
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma...
16 August 2011 | By kdm communications
The flexibility offered by Tecan’s MultiChannel Arm™ (MCA) 384 and Freedom EVO® liquid handling platform is vital to researchers...
16 August 2011 | By Abbott
Two strengths for three-month administration of Lupron Depot-PED ® approved...
16 August 2011 | By Bristol-Myers Squibb Company
Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” contest announced...
15 August 2011 | By Pfizer
Pfizer Inc. has prevailed in its patent infringement action against Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of VA...
15 August 2011 | By GlaxoSmithKline
Top-line results of the ASCEND-PD Phase III clinical study...
15 August 2011 | By Gilead Sciences
Phase 3 clinical trial met its primary objective...
11 August 2011 | By University of Brighton
One of the world’s most renowned “drug hunters” has been awarded an honorary Doctor of Science from the University of Brighton...
10 August 2011 | By Abbott
The U.S. FDA approved the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis...